Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/532878 stock hub

BOM/532878 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/532878is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/532878

In the news

Latest news · BOM/532878

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E12.8

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-4.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/532878 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

160

Groups with data

Currency

INR

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	453
Employees Change	43%
Employees Change Percent	10.49
Enterprise value	INR 99M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 1.5B
Price	INR 71.32
Price currency	INR
Rev Per Employee	2,523,913.91x
Sic	2834
Symbol	bom/532878
Website	https://www.alpalabs.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.8%
EV Earnings	0.85x
EV/Sales	0.09x
P/B ratio	0.81x
P/E ratio	12.82x
P/S ratio	1.3x
PE Ratio10 Y	18.03x
PE Ratio3 Y	10.84x
PE Ratio5 Y	12.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.28%
EBITDA Margin	-0.19%
Gross margin	26.16%
Gross Profit	INR 299.1M
Gross Profit Growth	-17.65%
Gross Profit Growth Q	-25.03%
Gross Profit Growth3 Y	-5.24%
Gross Profit Growth5 Y	-2.72%
Net Income	INR 116.1M
Net Income Growth	-53.92%
Net Income Growth Q	-78.62%
Net Income Growth3 Y	37.26%
Net Income Growth5 Y	10.82%
Pretax Margin	13.69%
Profit Margin	10.15%
Profit Per Employee	INR 256,267
Roa5y	2.62
Roe5y	10.57
ROIC	-4.36
Roic5y	8.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.4%
Cagr15y	13.27%
Cagr1y	-28.8%
Cagr3y	4.44%
Cagr5y	4.42%
EPS Growth	-53.82
EPS Growth Q	-78.72
EPS Growth3 Y	37.22
EPS Growth5 Y	10.84
Revenue Growth	18.93x
Revenue Growth Q	11.07x
Revenue Growth3 Y	4.32x
Revenue Growth5 Y	4.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.4B
Equity	INR 1.8B
Interest Coverage	-17.57
Net Cash	INR 1.4B
Net Cash By Market Cap	INR 93.35
Net Cash Growth	30%
Net Debt Equity	INR -0.76
Tangible Book Value	INR 1.8B
Tangible Book Value Per Share	INR 81.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	123.93%
1Y total return	-28.79%
200-day SMA	80.13
3Y total return	13.93%
50-day SMA	64.12
50-day SMA vs 200-day SMA	50under200
5Y total return	24.14%
All Time High	144.6
All Time High Change	-50.68%
All Time High Date	2024-09-30
All Time Low	5.5
All Time Low Change	1,196.73%
All Time Low Date	2011-12-20
ATR	3.63
Ch YTD	-7.84
High	73
High52	118.8
High52 Date	2025-05-28
High52ch	-39.97%
Low	69.81
Low52	46
Low52 Date	2026-03-30
Low52ch	55.04%
Ma50ch	11.23%
Price vs 200-day SMA	-10.99%
RSI	60.5
RSI Monthly	44.72
RSI Weekly	47.88
Sharpe ratio	-0.66x
Sortino ratio	-0.87
Total Return	0.23%
Tr YTD	-7.84
Tr15y	548.36%
Tr1m	3.42%
Tr1w	6.21%
Tr3m	1.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -26.1M
Operating Income Growth Q	348.7
Operating margin	-2.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,963,650%
Shares Insiders	57.4%
Shares Qo Q	-6.03%
Shares Yo Y	-0.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,879.9x
Bv Per Share	81.47
Ch10y	123.9
Ch15y	548.4
Ch1m	3.42
Ch1w	6.21
Ch1y	-28.79
Ch3m	1.55
Ch3y	13.93
Ch5y	24.14
Ch6m	-12.84
Change	1.89%
Change From Open	-2.3
Close	70
Days Gap	4.29
Depreciation Amortization	23,880,250
Dollar Volume	21,253.4
Earnings Date	2026-05-26
EBIT	INR -26.1M
EBITDA	INR -2.2M
EPS	INR 5.52
F Score	1
Fiscal Year End	March
Founded	1,988
Graham Number	104.82147
Graham Upside	46.97
Income Tax	INR 40.4M
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Lynch Fair Value	INR 60.19
Lynch Upside	-15.6
Ma150	74.31
Ma150ch	-4.02%
Ma20	68.58
Ma20ch	4%
Next Earnings Date	2026-05-26
Open	73
Position In Range	47.34
Price Date	2026-05-08
Ptbv Ratio	0.81
Relative Volume	0.16x
Revenue	1,143,333,000x
Tax By Revenue	3.53x
Tax Rate	25.82%
Tr6m	-12.84%
Volume	298

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/532878 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/532878 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/532878?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+57.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

BOM/532878 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.5

Neutral momentum band

Price vs 200-day MA

-11.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/532878

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/532878 stock rating?

bom/532878 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/532878 analysis?

The full report lives at /stocks/bom/532878/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/532878?

The latest report frames bom/532878 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/532878 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.